toxylact: a03fa01 metoclopramide

The first professional lActological database in the word

Metoclopramide (ATC A03FA01) is a dopamine D₂ receptor antagonist with prokinetic and antiemetic properties, widely used for functional gastrointestinal disorders and nausea, and relevant to lactation because it both passes into breast milk and can pharmacologically increase prolactin.medpedia.framar+3

ATC class and general pharmacology

Metoclopramide is the sole representative of ATC class A03FA01, within A03 “Drugs for functional gastrointestinal disorders” and subgroup A03F “Propulsives”.atcddd.fhi+1
It acts centrally as an antiemetic via D₂‑antagonism in the chemoreceptor trigger zone and peripherally as a prokinetic, enhancing motility of the upper gastrointestinal tract and accelerating gastric emptying.drugbank+2

Metoclopramide is indicated for nausea and vomiting of various origins, diabetic gastroparesis and gastro‑oesophageal reflux, and is used in chemotherapy‑ and radiotherapy‑induced emesis and perioperative settings.wikipedia+2
It is also used in pregnancy (e.g. hyperemesis gravidarum) and, off‑label, in migraine and as a galactagogue to attempt to increase milk supply.ncbi.nlm.nih+3

Toxicological profile

Metoclopramide has a relatively wide therapeutic window but a distinct neuropsychiatric and haematological adverse‑effect profile.medpedia.framar+2
Common dose‑related ADRs include fatigue, somnolence, agitation, akathisia, diarrhoea, and headache.wikipedia+1

Serious toxicities involve extrapyramidal symptoms (acute dystonia, oculogyric crisis, Parkinsonism), tardive dyskinesia (with prolonged or high‑dose use), neuroleptic malignant syndrome, and depression.droracle+2
Haematological events such as agranulocytosis, leukopenia, neutropenia, and methaemoglobinaemia are rare but documented, as are endocrine effects like hyperprolactinaemia, galactorrhoea and gynaecomastia.medpedia.framar+1

Cardiovascular responses include blood pressure fluctuations (hypertension or hypotension), while urinary frequency (pollakiuria) may also occur.medpedia.framar
Overdose or high infant exposure has been associated with extrapyramidal intoxication in breastfed children, underscoring the need for cautious lactational use.authorea+1

Lactation pharmacology and infant exposure

Metoclopramide is excreted into human milk in small quantities, typically below 10% of the maternal weight‑adjusted dose, which is generally considered compatible with breastfeeding from an exposure perspective.nhs+2
LactMed and other clinical sources describe milk concentrations as low and report few serious infant adverse effects in short‑term maternal therapy.ncbi.nlm.nih+1

Because metoclopramide increases serum prolactin in the mother, it has been used off‑label as a galactagogue, usually at 10 mg two to three times daily for up to 2–3 weeks, although robust evidence for increased milk volume is lacking.kjfm+2
A systematic review showed no meaningful improvement in milk output despite higher prolactin, and current expert opinion does not recommend routine use for low supply, favouring non‑pharmacological measures first.australianprescriber.tg+2

Reported infant effects are usually mild (e.g. transient gastrointestinal symptoms, unusual sleepiness), but a published case of extrapyramidal syndrome in a breastfed child demonstrates that clinically relevant toxicity is possible when exposure is high or the infant is particularly susceptible.medsafe+1
Consequently, most guidelines advise using the lowest effective maternal dose for the shortest duration, monitoring the infant for sedation, irritability, feeding difficulties, gastrointestinal disturbance, or abnormal movements.nhs+2

Lactological safety assessment and clinical recommendations

From a lactological perspective, metoclopramide can generally be considered compatible with breastfeeding when used short‑term at standard antiemetic or prokinetic doses, provided infant monitoring is in place.medsafe+2
However, its neuropsychiatric risk profile in the mother (depression, extrapyramidal reactions, tardive dyskinesia) and the documented case of infant intoxication justify a cautious, individualized risk–benefit evaluation.droracle+2

For maternal indications such as severe nausea, gastroparesis or reflux where metoclopramide is clinically necessary and alternatives are unsuitable, continuation of breastfeeding is usually acceptable, with attention to dosing and infant observation.ncbi.nlm.nih+2
Use as a galactagogue should be reserved for specialist supervision after optimization of non‑drug strategies (frequent feeding, latch correction, maternal hydration and nutrition), due to limited efficacy and potential for adverse effects.australianprescriber.tg+2

In toxicological‑lactological classification systems, metoclopramide is typically placed in a “compatible with caution” category: low milk transfer and low expected infant dose, but with non‑negligible risk of serious dopaminergic and extrapyramidal toxicity if exposure is excessive or prolonged.authorea+3
Documentation should therefore highlight dose, duration, maternal risk factors (e.g. psychiatric disease, prior EPS), infant vulnerability (preterm, neurological impairment) and recommend close clinical follow‑up when used during breastfeeding.nhs+2

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.